Immunohistochemistry-Paraffin: Nicotinic Acetylcholine R alpha 7/CHRNA7 Antibody [NBP1-52375] - Analysis of anti-CHRNA7 antibody with human hippocampus and isocortex. Image from verified customer review.
Immunohistochemistry-Paraffin: Nicotinic Acetylcholine R alpha 7/CHRNA7 Antibody [NBP1-52375] - Analysis of anti-CHRNA7 antibody with human brain, cortex at concentration 3 ug/ml.
Hu, Po, Bv, Ca, Ch, Eq, Pm, Mu, Rt, Ha, Ma-Op, RbSpecies Glossary
IHC: NBP1-52375 was validated for use in IHC on a panel of 21 IHC-P (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity.
Read 1 Review rated 5 using NBP1-52375 in the following applications:
FAQs for Nicotinic Acetylcholine R alpha 7/CHRNA7 Antibody (NBP1-52375). (Showing 1 - 3 of 3 FAQ).
I am doing research on Neuroscience and I would like to use some antibodies, especially in Western Blots, but I could do other assays: - alpha7 nicotinic cholinergic receptor; - parvalbumin; - calbindin D28K; The preferred reactivity is anti-human and anti-mouse. Do you have these antibodies? Are they in stock? And what about the prizes: How much are they? How much are the shipping costs? Could you make me any offer?
We currently have three alpha7 nicotinic cholingergic receptor antibodies available for purchase. Please see this list for our Parvalbumin antibodies. None are currently validated in mouse. I would like to introduce you to our Innovators Reward Program. We have an excelent calbinin D28K antibody that has been validated for use in human and mouse and WB. The pricing and availability of our products depends on your country.
I am looking to buy antibodies against most of the nicotinic receptor subunits for WB and IHC application. Could you please indicate which of your antibodies have been used by other researchers and provide publications showing their use? Thanks.
A list of our antibodies directed against he nicotinic acetylcholine receptors can be found here. Any products with publications will be indicated on the search page and can be found under the publications tab on the individual product's datasheet. Furthermore, we guarantee all of our products for the applications and species list on the datasheet. This should help narrow down your search.
Would you please tell me whether your antibody Nicotinic Acetylcholine R alpha 7/CHRNA7 Antibody (NBP1-52375) is suitable for detecting rat tissue which is PFA perfusion fixed frozen sections?
We have not tested this product on frozen sections yet but since it worked well in IHC-P, there is a great chance that it will work on IHC-Fr. Technically speaking, IHC-P protocol poses the target proteins/antigens to more harsh conditions/reagents compared to IHC-Fr, ICC-IF and FLOW protocols. And most of antibodies which work for IHC-P application works for IHC-Fr, ICC-IF and FLOW also. Therefore, I would highly encourage you to test this product in your experiments via our Innovator's Reward program. Innovators Reward
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.